Literature DB >> 6966720

Membrane versus bubble oxygenator for cardiac operations. A prospective randomized study.

E A Hessel, D D Johnson, T D Ivey, D W Miller.   

Abstract

The advantages of membrane oxygenators over bubble oxygenators for cardiopulmonary bypass during clinical cardiac operations are controversial. A prospective randomized double-blind experimental design was utilized in 64 adult patients undergoing elective cardiac operations with either the Travenol microporous polyprolyene membrane oxygenator or the Bentley Q-100 bubble oxygenator. Sixteen patients in each group underwent coronary artery bypass grafting (CABG) and 16 underwent valvular or other types of operation. The two oxygenator groups were comparable in terms of patient characteristics and perioperative management. Both oxygenators functioned acceptably for an average duration of 115 minutes. Higher relative platelet counts (percent of control) were observed immediately after bypass in CABG patients in whom the membrane oxygenator was used. Otherwise, no significant differences were noted in objectively assessed results between the two oxygenators in regards to bleeding, pulmonary, renal, cardiac, and neurologic function, duration of ICU stay, and postoperative hospital stay. Thus no significant advantages in terms of clinical results could be detected with this type of membrane oxygenator versus another type of bubble oxygenator for elective cardiac operations in adults.

Entities:  

Mesh:

Year:  1980        PMID: 6966720

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  A brief comparative study of four disposable bubble oxygenators.

Authors:  J Rubio Alvarez; M Fuster Siebert; C Iglesias Carreño; E Sevillano Estremera; R Blanco Iglesias; S Saavedra Pereira; J B Garcia-Bengochea
Journal:  Cardiovasc Dis       Date:  1981-06

2.  In vivo survival of red blood cells processed by a bubble or membrane oxygenator during cardiopulmonary bypass surgery.

Authors:  J E Ansell; T VanderSalm; W Stephenson; I Szymanski; L Fournier
Journal:  Tex Heart Inst J       Date:  1986-06

3.  Antiplatelet drugs: mechanisms and risks of bleeding following cardiac operations.

Authors:  Victor A Ferraris; Suellen P Ferraris; Sibu P Saha
Journal:  Int J Angiol       Date:  2011-03

4.  Clinical evaluation of the microporous hollow fiber oxygenator.

Authors:  H Makuuchi; A Mizuno; A Furuse; K Sudo; T Takayama; Y Kotsuka; T Takahama; K Asano
Journal:  Jpn J Surg       Date:  1984-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.